Morgan Stanley
RVMDW icon

Morgan Stanley’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Morgan Stanley’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.97K Buy
+2,216
New +$4.29K ﹤0.01% 7200

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Morgan Stanley's RVMDW Position: Q1 2026 in Review

Morgan Stanley opened a new position in Revolution Medicines Inc Warrant (RVMDW) in Q1 2026: 2,216 shares worth $3.97K. The stake represents ﹤0.01% of the portfolio and ranks #7200 among its holdings.

23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Morgan Stanley held 2,216 shares of Revolution Medicines Inc Warrant worth $3.97K as of Q1 2026.
  • Revolution Medicines Inc Warrant was a new Morgan Stanley position in Q1 2026.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7200 holding.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.